The Breakthrough T1D Clinical and Research Congress (CRC 2026), the inaugural congress of the Breakthrough T1D, took place from 9-11 October 2026 in Pennsylvania Convention Center, bringing together 1000 healthcare providers, researchers, industry partners and community advocates from across the T1D ecosystem from 33 countries.
The event provided a platform for knowledge exchange, collaboration and innovation, with a scientific and professional programme focused on immunotherapies, automated insulin delivery and islet cell therapies reflecting the latest developments and priorities across type 1 diabetes.
Across the two and a half days, participants engaged in:
- plenary sessions (changing the Future T1D Paradigm, Charting the Dynamic Evolution of T1D Care, Diabetic Ketoacidosis, From Somatic Cells to Therapeutic Solutions), workshops
- international speakers
- networking, collaboration, community exchange
The programme addressed key industry challenges and emerging trends in type 1 diabetes, supporting meaningful dialogue and knowledge sharing across the global community.
The congress went above and beyond all expectations when the project was first launched. Not only did the numbers exceed projections, but the scientific level and the enthusiasm of all participants clearly demonstrated that a dedicated meeting focused specifically on type 1 diabetes was both needed and highly valued by the community.
Scale and Participation
The congress welcomed 1000 participants from 33 countries, including clinicians, researchers, industry leaders and members of the T1D community, reinforcing its role as a global platform for collaboration, knowledge exchange and advancement in type 1 diabetes.
Partnership and Delivery
The congress was organised in collaboration with Breakthrough T1D and supported by Kenes Group, which provided event management and operational delivery, continuing a strong partnership focused on delivering high-quality, impactful global meetings.
Looking Ahead
The discussions and outcomes from the Breakthrough T1D Clinical and Research Congress (CRC 2026) are expected to contribute to research, collaboration and innovation, supporting the continued advancement of type 1 diabetes care, prevention and cures. Looking ahead, the next edition of the Breakthrough T1D Clinical and Research Congress will take place in Washington, DC, from 15-17 May 2027.
Media and Information
For more information, including programme highlights and future editions, visit: Breakthrough T1D Clinical & Research Congress (CRC 2026)
Media contact: Marcel Dekker
Email: [email protected]